Skip to main content
No.1 Press Release Service in Korea
Search
Search
Login
Create Account
Services
Contact Us
News
Services
About Us
Contact Us
Korean
News
All News
News by Region
Korea
Overseas
News by Industry
Health
Economy
Education
Finance
Technology
Life Style
Leisure
Culture & Entertainment
Transportation
Society
Heavy Industries
Environment
Government
Services
Why Korea Newswire?
How We Distribute
Services & Pricing
Basic
Standard
Premium
Global
Translation
Press Release Network in Korea
Korean Language
About Us
News
Services
Contact Us
Search
Cancel
Search
Submit Press Release
Latest News
News by Region
Korea
World
News by Industry
Health
Economy
Education
Finance
Technology
Life Style
Leisure
Culture & Entertainment
Transportation
Society
Heavy Industries
Environment
Government
Health News Releases
Today April 30
09:50
HistoSonics’ Histotripsy System Demonstrates 90% Local Tumor Control at 12 Months in #HOPE4LIVER Trials
HistoSonics (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fhistosonics.com%2F&esheet=54244430&newsitemid=20250428931117&lan=en-US&anchor=HistoSonics&index=1&md5=654c6b5b28f131e64dc
April 29, 17:10
SINOVAC Board Issues Letter to Shareholders to Set the Record Straight on the Hostile Actions and False Claims by Vivo Capital
Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that its board of directors (the “Board”) issued a public le
April 29, 15:30
Actus Nutrition Acquires Protein Facility from Foremost Farms USA
Actus Nutrition (“Actus”), a leading vertically-integrated nutritional ingredients manufacturer and portfolio company of Butterfly Equity (“Butterfly”), today finalized an agreement to purchase a 99,0
April 29, 09:50
Ferrer Enters Into a Collaboration and License Agreement With Prilenia for the Commercialization and Co-Development of Pridopidine
Ferrer (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.ferrer.com&esheet=54244013&newsitemid=20250427034068&lan=en-US&anchor=Ferrer&index=1&md5=d54ab3f5c9071597c756ac15dea5202e),
April 27, 11:30
Erbe introduces VIO® 3n & VIO® seal: Tailored electrosurgical generators for high-performance workflows
With the introduction of the VIO® 3n, Erbe Elektromedizin GmbH expands its established VIO® 3 family with a new generation of electrosurgical generators, specifically tailored to different medical spe
April 25, 10:00
PCI Pharma Services to Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea
PCI Pharma Services (“PCI”) - a leading global contract development and manufacturing organization (CDMO) focused on innovative biopharma therapies - is acquiring an entire equity stake in Ajinomoto A
April 24, 16:10
Grant Award from GHIT Fund for Development of an Ultrasensitive Urine Test for Tuberculosis
H.U. Group Holdings, Inc. and its wholly-owned subsidiary Fujirebio Holdings, Inc. today announced that the Global Health Innovative Technology (GHIT) Fund has awarded a two-year, approximately $4.5 m
April 24, 14:15
Galderma Delivers Record First Quarter Net Sales of 1.129 Billion USD, Including Strong Performance From Two Launches With Blockbuster Potential, and Confirms Full-Year Guidance
Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its sales performance for the first quarter of 2025. · Net sales: Achieved 1,129 million USD in net sales, u
April 24, 10:30
QPS Expands Offerings With Robust Pharmacology Disease Models, Including MASH, Ulcerative Colitis, Wound Healing, and Psoriasis
QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion of its pharmacology disease models p
April 23, 15:00
Invivoscribe’s LabPMM Gains New York State Approval for the FLT3 ITD MRD Assay
Invivoscribe is proud to announce that its wholly owned subsidiary, the Laboratory for Personalized Molecular Medicine® (LabPMM), LLC has received approval from the New York State Department of Health
April 23, 14:35
Global Health Experts Appointed to Judge Aster Guardians Global Nursing Award 2025, to Be Held in Dubai
Aster DM Healthcare, one of the leading integrated healthcare providers in GCC & India, has announced the distinguished Grand Jury panel for the Aster Guardians Global Nursing Award 2025 to be held in
April 22, 16:38
A new weapon in the global fight against malaria
Malaria is one of the world’s most deadly diseases, and it is becoming more pervasive - despite decades of effort and some successes on the path to eradicating it. According to the World Health Organi
April 22, 10:35
Novotech Identifies Strategic Opportunities in Idiopathic Pulmonary Fibrosis Trials with Release of Global Market Insights
Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory partner for biotech and small- to mid-sized pharmaceutical companies seeking to advance drug d
April 22, 10:20
Ferring Announces Initial Data from Phase 3 Trial in Japanese Patients Demonstrating 75% Complete Response Rate at 3 Months with (nadofaragene firadenovec) in BCG-unresponsive NMIBC Patients1
Ferring Pharmaceuticals presented the first results from an ongoing Phase 3 trial in Japan assessing the efficacy and safety of nadofaragene firadenovec in patients with high-risk Bacillus Calmette-Gu
April 20, 11:45
Rigaku and SPERA PHARMA Initiate Strategic Partnership to Advanced Pharmaceutical Development
Rigaku Corporation, a Group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; hereinafter “Rigaku”), and SPERA PHARMA, Inc. (headquarters: Osaka; President & Re
April 18, 09:55
Avania Strengthens Leadership Team With Pivotal Executive Appointments
Avania (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.avaniaclinical.com%2F&esheet=54239395&newsitemid=20250417247152&lan=en-US&anchor=Avania&index=1&md5=8135dbc072fb2e6f4bf0a0
April 18, 09:45
Abu Dhabi Launches Life Sciences Cluster to Advance Healthcare Innovation Worldwide, tapping a $25.3 trillion market
Abu Dhabi has launched the groundbreaking life sciences cluster, reinforcing its position as a global hub for biotechnology, MedTech, and digital health. Developed by the Abu Dhabi Department of Econo
April 17, 16:39
Galderma launches new ALASTIN Restorative Skin Complex with Next Generation TriHex Technology®
Galderma Group AG (SWX:GALD), the pure-play dermatology category leader, announced today that ALASTIN, a leader in medical-grade peptide-based regenerative skincare, has officially launched their late
April 17, 11:20
Kenvue Announces 5-Year Collaboration with Microsoft to Transform Digital Operations
Kenvue Inc. (NYSE: KVUE), maker of consumer health products like Tylenol®, Neutrogena® and Listerine®, today announced a five-year collaboration with Microsoft which aims to establish a strong foundat
April 15, 14:35
Galderma Launches Sculptra® in China, Further Fueling Its Growth Into One of the Fastest Growing Aesthetics Markets
Galderma today announced the launch of Sculptra, the first proven regenerative biostimulator with a unique poly-L-lactic acid (PLLA-SCA™) formulation, in China.[1]-[7],[11]-[14] This follows Sculptra’
April 13, 10:25
European Medicines Agency (EMA) Validates Henlius and Organon Filing for Perjeta® (pertuzumab) Biosimilar Candidate HLX11
Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN) today announced that the European Medicines Agency (EMA) has validated the marketing authorization application (MAA) for HLX11, an inve
April 13, 10:15
Novotech Welcomes New Investment From GIC, Temasek, and Existing Investor TPG to Accelerate Global Growth
Novotech, a globally recognized full-service biotech specialist clinical research organization (CRO), announced today that affiliates of GIC and Temasek have signed binding agreements to acquire a sig
April 10, 15:00
Natus Sensory Strengthens Executive Team with Key Leadership Appointments
Natus Sensory (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fnatus.com%2F&esheet=54235965&newsitemid=20250409771212&lan=en-US&anchor=Natus+Sensory&index=1&md5=c24865accf8cec644da2a
April 10, 14:20
New Coalition Calls for Urgent Action to Address Rising Stroke Crisis
Launching today, the world’s first multisector advocacy movement dedicated to stroke - the Global Stroke Action Coalition - has issued an urgent call to action to address growing inequities in stroke.
April 10, 13:55
Merz Aesthetics® Announces Salma Hayek Pinault as First-Ever Global Brand Ambassador for Ultherapy PRIME®, the Next Generation Platform for Nonsurgical Skin Lifting Treatments
Merz Aesthetics®, the world’s largest dedicated medical aesthetics business, is proud to announce world-renowned actress, director and producer, Salma Hayek Pinault, as the first-ever global brand amb
April 10, 11:40
BeiGene Provides Update on the Ociperlimab (BGB-A1217) Clinical Development Program
BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced the discontinuation of its clinical developmen
April 09, 15:28
Ferring achieved record sales driven by Reproductive Medicine combined with the emergence of Adstiladrin
Ferring achieved total revenues of €2.3 billion in 2024, an increase of 7% over the previous year at actual exchange rates (AER) and 8% at constant exchange rates (CER). This above market growth refle
April 07, 10:55
Center for Disease Analysis Foundation Awards Third Round of Grants for the CDAF Relink Program
Building on the progress of the first two rounds, the Center for Disease Analysis Foundation (CDAF) Relink program is pleased to announce seven hundred and eighty-two thousand dollars in funding for i
April 06, 11:00
Amazfit Announces the Bip 6 Smartwatch: The Everyday Smartwatch for Every Moment
Amazfit, a leading global smart wearable brand owned by Zepp Health (NYSE: ZEPP), a health technology company, today announced the launch of the Amazfit Bip 6 smartwatch (https://cts.businesswire.com/
April 04, 13:50
Parse Biosciences Partners with Japanese Distributor, SCRUM Inc.
Parse Biosciences, the leading provider of accessible and scalable single cell sequencing solutions, today announced an agreement with Tokyo-based SCRUM Inc. to expand its presence in Japan’s research
April 03, 11:25
ELIQUENT Life Sciences Announces Strategic Acquisition of Leading Pharmacovigilance Firm Truliant Consulting & Expanded Pharmacovigilance Platform
ELIQUENT Life Sciences (ELIQUENT), a global regulatory, quality, and safety consulting firm, today announced the acquisition of Truliant Consulting (Truliant), a leading pharmacovigilance, risk manage
April 03, 10:45
Novotech Report Reveals Global Surge in Infectious Disease Trials as Industry Nears 2,000 Studies Since 2020
Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory partner for biotech and small- to mid-sized pharmaceutical companies seeking to advance drug d
April 02, 09:15
Experts Set International and Multidisciplinary Collaboration As Priorities in Pulmonary Hypertension Management
The seventh edition of the International Meeting on Pulmonary Hypertension Clinical Treatment (IMPAHCT), organized by the pharmaceutical company Ferrer, gathered over 150 experts in pulmonology and ca
April 01, 17:00
Cell therapy for male urethral stricture: BEES-HAUS clinical application in Edogawa Hospital Japan, reports Dr. Akio Horiguchi in IMORU.
Urethral stricture affecting men of all ages, with increasing incidence after 55, is a recurring problem despite several treatment options. By transplanting autologous lab-engineered buccal tissue cel
April 01, 13:54
SINOVAC Announces Decision to Declare Cash Dividend
Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the Company’s board of directors (the “Board”) has deci
March 31, 15:40
GE HealthCare Completes Acquisition of Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan
GE HealthCare Technologies Inc. (GE HealthCare or the Company) (Nasdaq: GEHC) has completed its acquisition of the remaining 50% stake in Nihon Medi-Physics Co., Ltd (NMP), from Sumitomo Chemical, giv
March 30, 11:33
SINOVAC Announces New Board Member and Chairman of the Audit Committee
Sinovac Biotech Ltd. (NASDAQ:SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that its board of directors (the “Board”) has appointed Sven
March 28, 16:15
Invivoscribe Announces Registration of the LeukoStrat® CDx FLT3 Mutation Assay in the United Kingdom and Switzerland
Invivoscribe, a global leader in precision diagnostics, is pleased to announce the successful listings of the LeukoStrat CDx FLT3 Mutation Assay in both the United Kingdom (UK) and Switzerland. The Le
March 28, 10:35
Novotech Report Reveals Growth in siRNA Research: Over 150 Industry-Sponsored Clinical Trials Conducted from 2020 to 2024
Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company, has released its newest preclinical report exploring the evolving landscape of small
March 25, 14:25
Novotech Named Best Contract Research Organization in Australia at Asia-Pacific Biopharma Excellence Awards 2025
Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company that provides biotech and small- to mid-sized pharma companies an accelerated path to
March 25, 14:00
Swiss Virtual Clinic uniquely designed for Cataract Surgery
If you or someone you know is dealing with cataract surgery, sorting through the sheer volume of information can be overwhelming. Reliable details aren’t always easy to find, which is exactly why the
March 24, 11:50
Klick Health Acquires Ward6 Singapore
The world’s largest independent healthcare marketing agency Klick Health (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fbit.ly%2F3DB4ABI&esheet=54224919&newsitemid=20250317863187&l
March 24, 10:10
Caldera Medical Acquires Ethicon’s GYNECARE TVT™ Family of Products in Transformational Expansion Globally for Women’s Health Company
Caldera Medical, a leader in women’s health medical devices, has acquired Ethicon’s Gynecare TVT™ family of products and will transition the products in the coming months. This strategic milestone bui
March 23, 11:15
Parse Biosciences Expands Global Reach with the South Australian Genomics Centre as Certified Service Provider
Parse Biosciences, the leader in scalable and accessible single cell sequencing, is pleased to welcome the South Australian Genomics Centre (SAGC) (https://cts.businesswire.com/ct/CT?id=smartlink&url=
March 21, 11:15
Fujirebio Enhances Supply Chain Operations with Kinaxis
Kinaxis® (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.kinaxis.com%2Fen&esheet=54225864&newsitemid=20250319567981&lan=en-US&anchor=Kinaxis%26%23174%3B&index=1&md5=bc5fb9c28e34
March 21, 10:55
For the Second Time, Xenco Medical Is Named One of the World’s Most Innovative Companies by Fast Company Magazine
Pioneering medical technology company Xenco Medical has once again been named one of the World’s Most Innovative Companies by Fast Company Magazine. The esteemed annual list recognizes renowned compan
March 20, 15:36
AMWC 2025: Galderma Pushes the Innovation Frontier With Updates From Its Unparalleled Portfolio Designed to Meet the Needs of the Aesthetic Community
Galderma (SWX:GALD) will showcase a strong presence at the 23rd Aesthetic & Anti-Aging Medicine World Congress (AMWC) in Monaco from March 27-29, 2025, with two symposia, four Masterclass sessions, 11
March 20, 09:40
PHC and Cyfuse Develop Innovative Production Technology for the Commercialization of 3D Cell Products
PHC Corporation (Headquarters: Chiyoda-ku, Tokyo; President: Nobuaki Nakamura; hereafter referred to as “PHC”), a subsidiary of PHC Holdings Corporation (Headquarters: Chiyoda-ku, Tokyo; President: Ky
March 19, 17:20
Fujirebio Europe Launches the INNO-LiPA® HCV 2.0 Genotyping Assay, an Efficient Aid to Personalized HCV Therapy
Fujirebio Europe today announced the availability* of the INNO-LiPA HCV 2.0 Genotyping assay. The product, previously distributed by Siemens Healthcare Diagnostics Inc. under the name VERSANT HCV Geno
March 19, 15:05
Astronauts’ Health During Space Missions: Nichi BRITE and Neu REFIX Beta Glucans Could Benefit by Neutrophil-to-Lymphocyte Ratio, IL-6 Control, the Immune Biomarkers of Aging and Longevity
Neutrophil to Lymphocyte ratio (NLR) is a critical biomarker of health of astronauts during space mission, and that of aging related illnesses, inflammaging, longevity and cancer prognosis. Oral consu
March 19, 10:00
Novotech Partners with Kyungpook National University Hospital to Strengthen Clinical Trial Capabilities in South Korea
Novotech, a global leading full-service clinical Contract Research Organization (CRO), and Acrostar, a provider of Site Management Organization (SMO) services have entered into a strategic partnership
March 19, 09:26
SBC Medical Group to Announce Full Year 2024 Financial Results on March 28, 2025
SBC Medical Group Holdings Incorporated (NASDAQ: SBC, “SBC Medical”, or the “Company”), a global owner, operator and provider of management services and products to cosmetic treatment centers, today a
March 14, 16:50
Crown Bioscience Appoints John Gu as Chief Executive Officer
Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and a part of JSR Life Sciences and Japan-based JSR Corporation, has appointed John Gu as its new Chi
March 14, 15:32
Galderma Successfully Placed an Inaugural EUR 500 Million Single Tranche Eurobond and New Dual Tranche CHF 435 Million CHF Bonds
Galderma Group AG (SWX:GALD): NOT FOR DISTRIBUTION IN THE UNITED STATES OR IN ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE RESTRICTED BY APPLICABLE LAW OR REGULATION. Galderma (SIX
March 12, 17:15
Pharmaceutical Industry Issues Call for Collective Action to Address the Rising Global Burden of Chronic Disease
Ahead of a major UN milestone (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.who.int%2Fteams%2Fnoncommunicable-diseases%2Fon-the-road-to-2025%23Shaping%2520a%2520transformative
March 12, 11:05
Rigaku Wins Diana Nyyssonen Memorial Best Paper Award with Method for Inspecting and Measuring Defects in 3D Flash Memory
Rigaku Corporation, a Group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; hereinafter “Rigaku”) has won the Diana Nyyssonen Memorial Best Paper Award (herei
March 11, 16:40
Kenvue Announces Three New Appointments to Board of Directors
Kenvue Inc. (NYSE: KVUE), the world’s largest pure-play consumer health company by revenue, today announced the appointment of two new independent directors, Sarah Hofstetter, President of Profitero,
March 07, 13:30
BeiGene Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates
BeiGene (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.beigene.com%2F&esheet=54216036&newsitemid=20250227911272&lan=en-US&anchor=BeiGene&index=1&md5=e2cdff0a0d83750ab7730987260
March 07, 11:45
Novotech Releases Hepatitis B Global Clinical Trial Landscape Report 2025
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics, has released its
March 06, 17:30
InterSystems Unveils IntelliCare: A Next-Generation, AI-Powered Electronic Health Record
InterSystems (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.intersystems.com&esheet=54216543&newsitemid=20250304321284&lan=en-US&anchor=InterSystems&index=1&md5=2a1879be82b01b2
March 06, 15:45
Galderma Delivers 2024 Record Net Sales of 4.410 Billion USD, up 9.3% Year-on-Year at Constant Currency[1], and Record Core EBITDA of 1.031 Billion USD, While Preparing to Accelerate Its Growth Trajectory Into 2025 and Beyond
Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its financial results for the full year 2024, delivering strong results for another consecutive year while maki
March 06, 11:30
Parse Biosciences Advances Plans to Release Single Cell Chromatin Accessibility Products
Parse Biosciences, the leader in accessible and scalable single cell sequencing, today affirmed their plans to proceed with development and future release of their Evercode™ single cell chromatin prod
March 06, 10:10
Aster Guardians Global Nursing Award 2025 Worth $250,000 Extends Nomination Deadline to 9th March
Aster Guardians Global Nursing Award 2025 - an initiative by the leading integrated healthcare provider, Aster DM Healthcare, has extended the deadline for submission of nominations to 9th March, 2025
March 04, 10:49
Protagonist and Takeda Announce Positive Topline Results from Phase 3 VERIFY Study of Rusfertide in Patients with Polycythemia Vera
Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX (https://www.protagonist-inc.com/)) and Takeda (TSE:4502/NYSE:TAK (https://www.takeda.com/investors/overview/)) today announced positive top
March 03, 13:20
New Bipolar Disorder Study Shows that a Ketogenic Diet Leads to Mental and Physical Health Benefits
Baszucki Group today announced a new pilot study on a ketogenic diet in bipolar disorder. “For the first time in years, I felt like my brain was finally running on the right fuel,” said one of the stu
March 03, 12:00
Astria Therapeutics Initiates ALPHA-ORBIT Phase 3 Pivotal Trial of Navenibart in Hereditary Angioedema
Astria Therapeutics, Inc. (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fastriatx.com%2F&esheet=54215940&newsitemid=20250227320197&lan=en-US&anchor=Astria+Therapeutics%2C+Inc.&inde
March 03, 10:40
SINOVAC Announces New Board Pursuant to Privy Council Judgment and Order
Sinovac Biotech Ltd. (NASDAQ:SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that SINOVAC has received on February 8, 2025 a formal court
February 28, 16:30
Cynosure Lutronic and Amico Aesthetics Join Forces by Signing a Strategic Distribution Agreement for the Middle East
Cynosure Lutronic, a global leader in the energy-based devices market, has entered into a multi- country distribution agreement with Amico Aesthetics, a leader in providing world-class medical devices
February 28, 11:25
The Estée Lauder Companies Partners with Serpin Pharma, Inc to Develop Breakthrough Skin Care Ingredients to Advance Longevity
The Estée Lauder Companies Inc. (NYSE: EL) (ELC) today announced a collaboration with biotechnology company, Serpin Pharma, that aims to explore how their anti-inflammatory research can be applied in
February 27, 14:00
Triastek D23 (Budesonide Ileum Targeted Tablets) Receives Positive Clinical Results
Triastek announces that its 3D printed drug product D23 (Budesonide Ileum Targeted Tablets for the treatment of IgAN) has achieved positive results in recent clinical study. D23 is budesonide delayed-
February 26, 16:48
BROADMEDI and KHCA Sign Strategic MOU to Enhance Medical Tourism Services
BROADMEDI, a leading medical tourism platform of CREINNOS, has signed a strategic Memorandum of Understanding (MOU) with the Korea Hospital Coordinator Association (KHCA) to enhance service quality in
February 24, 16:43
KEYRESEARCH Launches ‘Aco-Alpha’ Nutr Supplement for Kids and Sells Out on First Day
KEYRESEARCH, a prominent name in health, announced the successful launch of its new product, ‘Aco-Alpha,’ on the 24th. It has been sold out immediately thanks to overwhelming demand. This sellout high
February 23, 13:20
ICC Arbitral Tribunal Rules in Favor of AOP Health in Arbitration Proceedings Pertaining to BESREMi® (Ropeginterferon alfa-2b)
Today, a tribunal under the auspices of the International Chamber of Commerce (ICC) served a partial final award in a dispute between PharmaEssentia Corp. (“PharmaEssentia”) and AOP Orphan Pharmaceuti
February 23, 11:50
Erectile Dysfunction: The PelviTouch Revolution Comes From DEKA’s Italian Technology
DEKA Laser, a subsidiary of El.En. S.p.A., a company operating in the Laser and Energy-Based Devices market, listed on Borsa Italiana’s Euronext STAR Milan (“STAR”), and a global leader in medical tec
February 23, 11:15
CareDx Announces Study Showing AlloSeq cfDNA Highly Accurate in Detecting Rejection in Organ Transplant Patients
CareDx, Inc. (Nasdaq: CDNA) - The Transplant Company™ - a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healt
February 21, 10:40
Ferrer is the Highest-performing Pharmaceutical Company in the World for Social and Environmental Impact According to B Corp
Spanish pharmaceutical company Ferrer has reaffirmed its status as a B Corp, an international certification awarded to companies that operate with a business model centered on positive impact and meet
February 21, 09:40
Variational AI Announces Oversubscribed $5.5 Million Financing to Launch Foundation Model for Small Molecule Drug Discovery
Variational AI, the company behind Enki™, an advanced foundation model for small molecule drug discovery, today announced the completion of its oversubscribed $US5.5 million Seed extension round. Enki
February 20, 09:17
Parse Biosciences Launches 5 Million Cell Evercode WT Penta Kit for Single Cell Sequencing
Parse Biosciences, the leader in high-throughput single cell sequencing, today announced the launch of Evercode™ WT Penta and Penta 384, the first single cell RNA sequencing kits to profile 5 million
February 19, 15:15
Italian Tennis Star Jasmine Paolini Joins Amazfit as Latest Athlete Ambassador
Amazfit, a leading global smart wearables brand owned by Zepp Health (NYSE: ZEPP), today announced the signing of Italian tennis sensation and World No. 4 Jasmine Paolini as its newest global athlete
February 19, 11:00
Novotech Partners with Wonju Severance Christian Hospital to Drive Clinical Research Excellence in Korea
Novotech, a global full-service clinical Contract Research Organization (CRO) that partners with biotech and small to mid-size pharma companies to accelerate the development of advanced and novel ther
February 18, 15:20
Galderma’s Nemluvio® (Nemolizumab) Granted Marketing Authorization in the United Kingdom and Switzerland for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis
Galderma today announced that the United Kingdom (UK) Medicines and Healthcare products Regulatory Agency and Swissmedic have granted the marketing authorization of nemolizumab for the treatment of bo
February 16, 09:30
Five-Time Olympic Medalist Gabby Thomas Joins Amazfit as Athlete Ambassador
Amazfit, a leading global smart wearables brand owned by Zepp Health (NYSE: ZEPP), is proud to announce five-time Olympic Medalist and fashion icon, Gabby Thomas, as the latest ambassador to join the
February 14, 15:45
Galderma’s Nemluvio® (Nemolizumab) Approved in the European Union for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis
Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic dermatitis and prurigo nodularis in the European Union (EU). Nemluvio is now a
February 11, 11:30
PHC and CCRM Collaborate to Develop Primary T-Cell Expansion Culture Processes to Enhance Efficiency and Improve Cell Quality
PHC Corporation has signed a Master Collaboration Agreement with CCRM to work together on the development of primary T-cell(*1) expansion culture processes that will seek to accelerate the manufacturi
February 06, 09:35
Parse Biosciences Invalidates All 10x Genomics’ Patent Claims Asserted Against Its Products
Parse Biosciences (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.parsebiosciences.com%2F&esheet=54199035&newsitemid=20250204152815&lan=en-US&anchor=Parse+Biosciences&index=1&md
February 04, 16:35
ELIQUENT Life Sciences Announces: Rob Wojciechowski Named Chief Operations Officer
ELIQUENT Life Sciences (ELIQUENT), a global regulatory, quality, and safety consulting firm, today announced the appointment of Rob Wojciechowski as Chief Operations Officer (COO). In this new role, R
January 31, 17:24
GE HealthCare Invests $138 Million in Cork, Ireland Manufacturing Facility to Address Increasing Contrast Media Demand
GE HealthCare (Nasdaq: GEHC) today announced a $138 million investment to expand its Carrigtohill, Cork contrast media fill and finish manufacturing site in Ireland. A new state-of-the-art facility on
January 31, 15:37
IMCAS 2025: New Galderma Phase IIIb Data Reinforce Rapid Onset and Long-lasting Aesthetic Improvement with RelabotulinumtoxinA (Relfydess™)
Galderma (SWX:GALD), the pure-play dermatology category leader, announced today results from its new phase IIIb RELAX clinical trial demonstrating the rapid onset and the long-lasting duration of aest
January 31, 14:25
Ferrer is Recognized for Its Best-in-class Ethics and Compliance Program
Ferrer has achieved Compliance Leader Verification™, the prestigious recognition granted by Ethisphere, which distinguishes the pharmaceutical company as a global leader in upholding ethical and respo
January 31, 13:12
Julie Kim Will Succeed Christophe Weber as CEO of Takeda in June 2026
Takeda (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.takeda.com&esheet=54196039&newsitemid=20250129509380&lan=en-US&anchor=Takeda&index=1&md5=98fdda2da61995100aa6dbd136297ebe)
January 31, 09:30
Brandnew Clinic Celebrates 15th Anniversary with Exclusive Promotions and Events
Brandnew Clinic (www.brandnewclinic.com) has announced a month-long celebration in February to commemorate its 15th anniversary and express gratitude to its loyal clients. Under the leadership of Dr.
January 30, 15:50
Takeda Delivers Strong Third-Quarter FY2024 Results; Raises Full Year Outlook, Forecasting Revenue and Core Operating Profit Margin Growth
Takeda (TOKYO:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Fstock-information%2F&esheet=54191699&newsitemid=20250127274764&lan=en-US&anc
January 30, 15:35
Galderma Demonstrates Injectable Aesthetics Leadership in Medication-Driven Weight Loss With New Research and First International Consensus-Based Guidelines
Galderma, the pure-play dermatology category leader, is pioneering new research into the impact of medication-driven weight loss on the skin and the importance of factoring in aesthetic treatment goal
January 30, 11:55
ImmunoMet Therapeutics Presents Updated Clinical Data from Phase 1b Study of Lixumistat in Pancreatic Cancer at ASCO-GI Meeting
ImmunoMet Therapeutics, Inc., (“ImmunoMet”, or the “Company”), a clinical stage biotechnology company committed to giving patients a novel approach to fight cancer, today provided a data update from t
January 24, 11:15
LTIMindtree Renews its Strategic Alliance with the Association of American Medical Colleges (AAMC)
LTIMindtree (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.ltimindtree.com%2F&esheet=54183242&newsitemid=20250120318350&lan=en-US&anchor=LTIMindtree&index=1&md5=f780cd94b90cf27
January 23, 15:24
IMCAS 2025: Galderma’s Broad Presence and New Data on Recently Launched Products Restylane® SHAYPE™ and Relfydess® Reaffirm Its Category Leadership
Galderma will present the latest updates from its innovative aesthetics portfolio at the International Master Course on Aging Science (IMCAS) World Congress 2025 on January 30 - February 1 in Paris, F
January 23, 11:10
Novotech Releases Comprehensive Report on Oncolytic Virus Therapy
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech and small to mid-size pharma companies to accelerate the development of advanced and novel th
January 22, 14:35
New Report Reveals Alarming Decline in Women’s Cancer Testing Worldwide
Women’s cancer testing has declined globally, according to the latest Hologic Global Women’s Health Index (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwomenshealthindex.com&esheet
January 21, 11:30
Biocytogen and Acepodia Join Forces to Advance Bispecific Antibody and Dual-Payload ADCs for Treating Complex Tumors
Biocytogen (HKEX: 02315) and Acepodia (6976:TT), today announced a groundbreaking strategic partnership to jointly assess a dual-payload bispecific antibody-drug conjugate (BsAD2C) program. This co
January 17, 14:30
Novotech Releases Report on Current State of Triple-Negative Breast Cancer Clinical Trials
Novotech, the leading global full-service clinical Contract Research Organization (CRO), has released a comprehensive report analyzing the global clinical trial and drug development landscape for Trip
1
2
3
4
5
»
100 per page
25 per page
50 per page
75 per page
100 per page
Distribute Your News to
KOREA
The largest press release distribution network in Korea
34,000 journalists
7,000 media outlets
345 industry channel
80,000 subscribers
Get Started
Global PR service
Reach Your Target
Audience in 160 Countries
powered by
Get Started
News by region
Korea
Overseas
News by industry
Health
Economy
Education
Finance
Technology
Life Style
Leisure
Culture & Entertainment
Transportation
Society
Heavy Industries
Environment
Government
Notice
